The takeover tussle for NHS landlord Assura has taken another twist as US private equity giant KKR urged the firm to switch its backing from rival suitor PHP, while the UK competition watchdog stepped in with further action. A consortium led by KKR has called on Assura’s board to change its recommendation for the £1.79 billion offer from healthcare property firm PHP (Primary Health Properties), arguing the case for its lower cash offer of £1.7 billion. It came as the UK competition watchdog served an initial enforcement order to block Primary Health Properties from fully integrating Assura while it looks into the deal. The Competition and Markets Authority (CMA) launched a consultation last month into PHP’s agreed takeover for Assura, in what marked the first step ahead of a formal investigation. Assura owns more than 600 buildings, including doctors’ surgeries, with a portfolio valued at about £3.1 billion. It has about 80 employees. PHP won backing from Assura’s board in June for a £1.79 billion offer following a lengthy bidding war with rival suitor KKR, which has teamed up with US investor Stonepeak for its bid. PHP increased its offer from an initial £1.68 billion bid in May, having been trumped by KKR and Stonepeak’s £1.7 billion move. The KKR consortium said on Friday it had held talks with Assura’s board in recent days to urge them to back its bid, saying that “a number of factors have changed” which make PHP’s offer less attractive. It claims that its cash offer is now 1.1% higher than PHP’s because of a decline in the shares prices of both PHP and Assura in recent weeks. KKR’s team also claimed that its offer had “no competition or antitrust risk” and is “able to provide the strongest ongoing stewardship for Assura, its team and all stakeholders including investing in NHS infrastructure”. View Comments
Bidding battle for Assura heats up as competition watchdog takes further action
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...